These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3046408

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Efficacy of levocabastine in perennial rhinitis].
    Pacor ML, Biasi D, Maleknia T, Carletto A, Lunardi C.
    Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
    [Abstract] [Full Text] [Related]

  • 24. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ, Lund VJ, Harten-Ash VJ.
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [Abstract] [Full Text] [Related]

  • 25. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W, Wiseman LR.
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J, Mercer M.
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of vasomotor rhinitis with intranasal beclomethasone dipropionate (Becotide). Results from a double-blind cross-over study.
    Löfkvist T, Svensson G.
    Acta Allergol; 1976 Jun; 31(3):227-38. PubMed ID: 782135
    [Abstract] [Full Text] [Related]

  • 33. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S, McTavish D.
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [Abstract] [Full Text] [Related]

  • 34. Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
    Valero A, Serrano C, Bartrá J, Izquierdo I, Muñoz-Cano R, Mullol J, Picado C.
    J Investig Allergol Clin Immunol; 2009 Dec; 19(6):488-93. PubMed ID: 20128424
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M, Pipkorn U.
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [Abstract] [Full Text] [Related]

  • 39. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
    LaForce CF, Dockhorn RJ, Findlay SR, Meltzer EO, Nathan RA, Stricker W, Weakley S, Field EA, Rogenes PR.
    J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.